However, LiquiCarns manufacturer, RxVitamins, does not have any data on LiquiCarn in dogs with current/prior hepatic encephalopathy
We need to be cautious when comparing results from different trials, as the design can inherently influence outcomes
Experience fewer cravings, more balance, and a healthier relationship with food all in one simple daily capsule
Based on these findings, the authors concluded that tirzepatide significantly reduced kidney disease progression compared with dulaglutide in patients with T2DM and atherosclerotic cardiovascular disease, lowering the primary composite kidney outcome across all CKD risk subgroups and slowing annual eGFR decline, suggesting a potential additional kidney benefit of dual agonism in this high-risk population.
So, wow, theres a lot of reasons to be very optimistic about these drugs
Developed by Metabolic Pharmaceuticals as a candidate anti-obesity agent